• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶原复合物浓缩物中的蛋白C抗原:含量、回收率及半衰期

Protein C antigen in prothrombin complex concentrates: content, recovery and half life.

作者信息

Riess H, Binsack T, Hiller E

出版信息

Blut. 1985 May;50(5):303-6. doi: 10.1007/BF00319757.

DOI:10.1007/BF00319757
PMID:3846459
Abstract

Protein C, a potent anticoagulant, has been detected in large amounts in some prothrombin complex concentrates (PCC). We extended these findings to eight PCC commercially available in West Germany detecting 0.82 to 1.92 plasma equivalent units of protein C antigen (PC:Ag) per unit factor IX. Infusion of PCC in four patients on stable oral anticoagulation resulted in a recovery of 58.6 +/- 10.9%. Estimated from the decrease in plasma levels of PC:Ag half life was 7.9 +/- 0.6 h.

摘要

蛋白C是一种强效抗凝剂,在一些凝血酶原复合物浓缩剂(PCC)中已检测到大量存在。我们将这些研究结果扩展至在西德市售的8种PCC,发现每单位因子IX含有0.82至1.92血浆当量单位的蛋白C抗原(PC:Ag)。对4例接受稳定口服抗凝治疗的患者输注PCC后,回收率为58.6±10.9%。根据PC:Ag血浆水平的下降情况估算,半衰期为7.9±0.6小时。

相似文献

1
Protein C antigen in prothrombin complex concentrates: content, recovery and half life.凝血酶原复合物浓缩物中的蛋白C抗原:含量、回收率及半衰期
Blut. 1985 May;50(5):303-6. doi: 10.1007/BF00319757.
2
In vitro characterization of various heat-treated prothrombin complex concentrates (PCC).各种热处理凝血酶原复合物浓缩剂(PCC)的体外特性研究。
Thromb Res. 1987 Aug 15;47(4):449-58. doi: 10.1016/0049-3848(87)90460-9.
3
Protein C survival during replacement therapy in homozygous protein C deficiency.纯合子蛋白C缺乏症替代治疗期间蛋白C的存活情况。
Am J Hematol. 1992 Sep;41(1):24-31. doi: 10.1002/ajh.2830410106.
4
Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers.健康志愿者中贝曲泊帕/凝血酶原复合物浓缩剂的药代动力学
Thromb Haemost. 2007 Oct;98(4):790-7.
5
Plasma levels of protein C and protein S in patients with vasculopathy.血管病变患者的血浆蛋白C和蛋白S水平。
Thromb Res. 1987 Mar 15;45(6):857-63. doi: 10.1016/0049-3848(87)90096-x.
6
[Measurement of Gla proteins by dot method and clinical study (protein S, protein C, and prothrombin)].[采用斑点法测定Gla蛋白及临床研究(蛋白S、蛋白C和凝血酶原)]
Nihon Sanka Fujinka Gakkai Zasshi. 1988 Oct;40(10):1535-42.
7
[Studies on the assay method of protein C and changes of vitamin K dependent coagulation factors including protein C in the cases with warfarin treatment].[华法林治疗病例中蛋白C测定方法及包括蛋白C在内的维生素K依赖性凝血因子变化的研究]
Rinsho Byori. 1986 Apr;34(4):464-8.
8
Comparative in vitro investigation of prothrombin complex concentrates.
Semin Thromb Hemost. 1998;24(2):175-81. doi: 10.1055/s-2007-995838.
9
Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrate.与凝血酶原复合物浓缩物相比,输注高纯度IX因子浓缩物后凝血激活减少。
Br J Haematol. 1993 Jun;84(2):279-84. doi: 10.1111/j.1365-2141.1993.tb03065.x.
10
Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy.开始口服抗凝治疗后不久,蛋白C抗原减少并形成异常蛋白。
Br J Haematol. 1984 Jun;57(2):213-20.

引用本文的文献

1
A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.维生素 K 依赖的凝血因子和抗凝蛋白的联合模型。
Clin Pharmacokinet. 2017 Dec;56(12):1555-1566. doi: 10.1007/s40262-017-0541-5.
2
Evaluation of a new protein-C concentrate and comparison of protein-C assays in a child with congenital protein-C deficiency.
Ann Hematol. 1992 Mar;64(3):146-51. doi: 10.1007/BF01697402.

本文引用的文献

1
Protein C deficiency in a Dutch family with thrombotic disease.一个患有血栓性疾病的荷兰家族中的蛋白C缺乏症。
Thromb Haemost. 1982 Aug 24;48(1):1-5.
2
Amino acid sequence of the light chain of bovine protein C.牛蛋白C轻链的氨基酸序列。
J Biol Chem. 1982 Oct 25;257(20):12170-9.
3
Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation.蛋白C是一种抗血栓形成蛋白,在患有血管内凝血的住院患者中含量降低。
Blood. 1982 Jul;60(1):261-4.
4
Deficiency of protein C in congenital thrombotic disease.先天性血栓形成性疾病中的蛋白C缺乏症。
J Clin Invest. 1981 Nov;68(5):1370-3. doi: 10.1172/jci110385.
5
Generation of fibrinolytic activity by infusion of activated protein C into dogs.通过向犬类输注活化蛋白C产生纤溶活性。
J Clin Invest. 1981 Nov;68(5):1221-8. doi: 10.1172/jci110368.
6
Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme.人活化蛋白C(一种凝血酶依赖性抗凝酶)的作用机制。
Blood. 1982 May;59(5):1067-72.
7
Inactivation of human coagulation factor V by activated protein C.活化蛋白C对人凝血因子V的灭活作用。
J Biol Chem. 1983 Feb 10;258(3):1914-20.
8
The fibrinolytic system in patients with congenital protein C deficiency.先天性蛋白C缺乏症患者的纤溶系统。
Thromb Res. 1984 Nov 15;36(4):363-7. doi: 10.1016/0049-3848(84)90328-1.
9
Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy.开始口服抗凝治疗后不久,蛋白C抗原减少并形成异常蛋白。
Br J Haematol. 1984 Jun;57(2):213-20.
10
Activated protein C inhibitor.活化蛋白C抑制剂
Semin Thromb Hemost. 1984 Apr;10(2):154-61. doi: 10.1055/s-2007-1004418.